Comparative study of RBE and cell survival fractions for 1^{1}H, 4^{4}He, 12^{12}C and 16^{16}O beams using Geant4 and Microdosimetric Kinetic model

preprint2014arXivOpen access

Abstract

Beams of 4^{4}He and 16^{16}O nuclei are considered for ion-beam cancer therapy as alternative options to protons and 12^{12}C nuclei. Spread-out Bragg peak (SOBP) distributions of physical dose and relative biological effectiveness for 10% survival are calculated by means of our Geant4-based Monte Carlo model for Heavy Ion Therapy (MCHIT) and the modified microdosimetric kinetic model. The depth distributions of cell survival fractions are calculated for 1^{1}H, 4^{4}He, 12^{12}C and 16^{16}O for tissues with normal (HSG cells), low and high radiosensitivity. In each case the cell survival fractions were compared separately for the target volume, behind and in front of it. In the case of normal radiosensitivity 4^{4}He and 12^{12}C better spare tissues in the entrance channel compared to protons and 16^{16}O. The cell survival fractions calculated, respectively, for the entrance channel and target volume are similar for 4^{4}He and 12^{12}C. When it is important to spare healthy tissues located after the distal edge of the SOBP plateau, 4^{4}He can be recommended due to reduced nuclear fragmentation of these projectiles. No definite advantages of 16^{16}O with respect to 12^{12}C were found, with the except of an enhanced impact of these heavier projectiles on radioresistant tumors.

Explore this paper’s authors, topics and related work.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Reviews 0

Write a reviewWrite

No reviews yet.

Discussion 0

Add a commentWrite

No comments yet.